Highlights

  • Profit after tax was $109,171 in FY26, against a loss of $128,795 in the prior year.
  • Customer revenue rose to $3.09 million from $2.23 million, and operating cash flow turned positive at $127,028.
  • R&D incentives of $349,527 supported the result, and cash closed at $637,641 with net assets of $1.36 million.
  • Shareholders vote on 27 November 2026 on the remuneration report, a director re-election and a 10% placement capacity.

Oakridge International Limited (ASX:OAK) swung back to profit in the year to 30 June 2026. The Adelaide-registered healthcare technology company, which sells nurse call systems through its JCT Healthcare subsidiary, lifted customer revenue to $3.09 million and turned operating cash flow positive.

Company Snapshot

Oakridge says it sells professional healthcare technology equipment and solutions to healthcare facilities. Its subsidiary, JCT Healthcare Pty Ltd, develops the NuCaMS and NuCaMS Enterprise nurse call hardware and software used in hospitals, aged care, disability care and supported independent living.

All FY26 revenue came from a single healthcare technology segment, entirely within Australia. The company also holds a 45% interest in the Sokoria geothermal project in Indonesia, which is fully impaired. It is exploring assisted independent living, Internet of Things and AI opportunities, which it describes as early stage and subject to ongoing evaluation.

FY26 Results

Revenue and other income was $3,446,008, against $2,433,340, while revenue from contracts with customers was $3,094,420, against $2,230,247. Profit after tax was $109,171, against a loss of $128,795. The result included research and development incentives of $349,527, up from $202,827.

Operating cash flow was a $127,028 inflow, against an outflow of $358,457, though it also includes the $349,527 of R&D receipts. Cash rose to $637,641 from $468,939, and net assets increased to $1,361,413 from $902,246. Net tangible assets were 4.08 cents per security. No dividend was declared.

Capital and Governance

Shares on issue rose to 31,997,851 from 26,997,908 after 4,999,943 shares were issued on 30 June 2026 on exercise of options at $0.07 by Montague Capital, an entity associated with chief executive Con Unerkov. A further 2,142,914 options expired unexercised, and 906,450 unlisted options at $0.10 remain, expiring in November and December 2026.

The 2026 AGM is on 27 November 2026 at 10.30am at the Adelaide office. Resolutions cover the remuneration report, the re-election of Wally Pastuch and approval of the 10% placement capacity under Listing Rule 7.1A.

Outlook and Risks to Watch

Management expects current channel activity and project conversion to support revenue into FY2027. The company points to Australia's ageing population and a persistent aged-care workforce shortfall as factors expected to support long-term demand, alongside rising government aged-care funding.

Risks include dependence on R&D incentives for the profit, no undrawn borrowing facilities and cash held at one bank. The company also reports an unquantified possible liability linked to representations in a 2019 share placement, a contingent grant obligation of $269,434 and a fully impaired receivable of $937,818 linked to the Indonesian project. Earlier reports flagged going concern dependence on equity raising and growth.

Stock Price Information

Oakridge International shares were unchanged at A$0.08 on 27 October 2026, giving the company a market capitalisation of about A$2.56 million. The stock is down 18.37% over the past year.